Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer

NCT00193362 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Gemcitabine
DRUG: Vinorelbine

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]